Conference Chair
Roger Kamm Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) |
Keynote Speakers
Albert Folch Professor of Bioengineering, University of Washington |
Shay Soker Professor of Regenerative Medicine and Chief Science Program Officer, Wake Forest Institute for Regenerative Medicine |
Roger Kamm Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) |
Peter Ertl Professor of Lab-on-a-Chip Systems, Vienna University of Technology |
James Hickman Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos |
OverviewWelcome to the SelectBIO 2D-to-3D Culture and Organoids 2020 Conference to be held August 19-20, 2020 in Boston. This
conference brings together the innovations in 3D-Culture and Organoids, circa 2020
and bring the key opinion leaders and thought leaders in the field from
around the world for two intensive days of scientific presentations,
networking as well as engagement with companies developing innovations
in tools and technologies in this expanding space. This conference was originally scheduled for March 25-26, 2020 in Boston but rescheduled due to the worldwide Coronavirus situation. All registrations, sponsors and exhibitors for the March 2020 meeting have been automatically rolled-over to this meeting. All visitors entering Massachusetts, including returning residents, who do not meet an exemption, are required to:
Complete
the Massachusetts Travel Form prior to arrival, unless you are visiting
from a lower-risk state (VT, NH, ME, CT, NY, NJ, HI)
Quarantine
for 14 days or produce a negative COVID-19 test result that has been
administered up to 72-hours prior to your arrival in Massachusetts. If
your COVID-19 test result has not been received prior to arrival,
visitors, and residents must quarantine until they receive a negative
test result. Failure to comply may result in a $500 fine per day. Please kindly follow the government guidelines carefully.
SelectBIO Conference Safety Guidelines Relating to COVID-19
Agenda Topics- 3D Culture to Organoid to Organ-on-a-Chip Continuum
- Case Studies using Organoids in Research, High Throughput Screening and Personalized Medicine
- Converting from 2D to 3D Culture Models
- Development and use of Advanced Microfluidic Chip Devices for Studying Organoids
- Emerging Technologies for Reproducible Production of Organoids
- High Content Imaging and Phenotypic Assays of 3D Culture Models
- Organoid Models for Studying Infectious Diseases
- Organoids-on-a-Chip
- Spheroids -- 3D Aggregates of Cells in Culture
- Tumor Organoids
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateJeffrey Borenstein, Group Leader, Synthetic Biology; Director, Biomedical Engineering Center, Draper Jake Boy, Senior Application Scientist, Scientific Bioprocessing Milos Kostic, Researcher, Novartis Institutes for BioMedical Research Ryuji Morizane, Assistant Professor, Harvard Medical School; Visiting Scholar, Wyss Institute Shubhankar Nath, Senior Oncology Scientist, CELLINK René Overmeer, Assay Development & Screening Manager, Hubrecht Organoid Technology (HUB) Terry Riss, Senior Product Manager, Cell Health, Promega Corporation Jennifer Rosenbluth, Instructor in Medicine, Dana-Farber Cancer Institute Matthew Shipton, Vice President and General Manager, Novabiosis Matthias von Herrath, Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute Qin Wang, Scientist, Drug Safety Research & Evaluation, Takeda Pharmaceuticals, Inc.
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|